Krystal Biotech Reports Strong Q1 2026 Earnings, Eyes Upcoming Pipeline Catalysts
Krystal Biotech Inc. (NASDAQ: KRYS) announced its first‑quarter 2026 financial results on May 4, 2026, revealing a 26 ...
Read story →
Krystal Biotech Inc. (NASDAQ: KRYS) announced its first‑quarter 2026 financial results on May 4, 2026, revealing a 26 ...
Read story →
On May 29, 2026, Twist Bioscience’s chief legal officer, Dennis Cho, made headlines by liquidating nearly a quarter‑...
Read story →